SV2002000776A - NEW SUBSTITUTED IMIDAZOTRIAZINONES REF.LEA 34 985-SV - Google Patents

NEW SUBSTITUTED IMIDAZOTRIAZINONES REF.LEA 34 985-SV

Info

Publication number
SV2002000776A
SV2002000776A SV2001000776A SV2001000776A SV2002000776A SV 2002000776 A SV2002000776 A SV 2002000776A SV 2001000776 A SV2001000776 A SV 2001000776A SV 2001000776 A SV2001000776 A SV 2001000776A SV 2002000776 A SV2002000776 A SV 2002000776A
Authority
SV
El Salvador
Prior art keywords
lea
ref
new substituted
substituted imidazotriazinones
imidazotriazinones
Prior art date
Application number
SV2001000776A
Other languages
Spanish (es)
Inventor
Ulrich Niewohner
Dagmer Schauss
Martin Hendrix
Gerhard Konig
Frank Gerhard Boss
Der Staay Franz Josef Van
Rudy Schreiber
Karl-Heinz Schlemmer
Rolf Grosser
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SV2002000776A publication Critical patent/SV2002000776A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVAS IMIDAZOTRIAZINONAS SUSTITUIDAS, A PROCEDIMIENTOS PARA SU PREPARACION Y A SU USO PARA LA PREPARACION DE MEDICAMENTOS, ESPECIALMENTE PARA LA MEJORA E LA PERCEPCION, LA CAPACIDAD DE CONCENTRACION, LA CAPACIDAD DE APRENDIZAJE Y/O LA CAPACIDAD DE MEMORIA.THE PRESENT INVENTION REFERS TO NEW REPLACED IMIDAZOTRIAZINONES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE FOR THE PREPARATION OF MEDICINES, ESPECIALLY FOR THE IMPROVEMENT AND PERCEPTION, THE CAPACITY OF CONCENTRATION, THE CAPACITY OF LEARNING AND LEARNING / CAPACITY.

SV2001000776A 2000-12-21 2001-12-20 NEW SUBSTITUTED IMIDAZOTRIAZINONES REF.LEA 34 985-SV SV2002000776A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10064105A DE10064105A1 (en) 2000-12-21 2000-12-21 New substituted imidazotriazinones

Publications (1)

Publication Number Publication Date
SV2002000776A true SV2002000776A (en) 2002-12-02

Family

ID=7668333

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2001000776A SV2002000776A (en) 2000-12-21 2001-12-20 NEW SUBSTITUTED IMIDAZOTRIAZINONES REF.LEA 34 985-SV

Country Status (15)

Country Link
US (1) US6573263B2 (en)
EP (1) EP1347978B1 (en)
JP (1) JP2004525098A (en)
AR (1) AR034423A1 (en)
AU (1) AU2002216087A1 (en)
CA (1) CA2431965A1 (en)
DE (2) DE10064105A1 (en)
DO (1) DOP2001000297A (en)
ES (1) ES2248228T3 (en)
GT (1) GT200100254A (en)
HN (1) HN2001000281A (en)
PE (1) PE20020756A1 (en)
SV (1) SV2002000776A (en)
UY (1) UY27080A1 (en)
WO (1) WO2002050078A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087605B2 (en) 2001-06-01 2006-08-08 Bayer Aktiengesellschaft 5-Ethyl-imidazotriazinones
GB0113342D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 1
DE60320529T2 (en) * 2002-02-04 2009-06-10 F. Hoffmann-La Roche Ag CHINOLINE DERIVATIVES AS NPY ANTAGONISTS
CA2489251A1 (en) * 2002-07-05 2004-01-15 F. Hoffmann-La Roche Ag Quinazoline derivatives
CA2493712A1 (en) * 2002-08-07 2004-02-19 F. Hoffmann-La Roche Ag Aminothiazole derivatives as npy5 receptor inhibitors
JP2006219374A (en) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Imidazotriazinone derivative having pde 7 inhibition
UA115057C2 (en) 2012-04-25 2017-09-11 Такеда Фармасьютікал Компані Лімітед Nitrogenated heterocyclic compound
EP2873669A4 (en) * 2012-07-13 2015-11-25 Takeda Pharmaceutical Heterocyclic compound
WO2014142255A1 (en) 2013-03-14 2014-09-18 武田薬品工業株式会社 Heterocyclic compound
JP6411342B2 (en) 2013-07-03 2018-10-24 武田薬品工業株式会社 Amide compounds
JP6427491B2 (en) 2013-07-03 2018-11-21 武田薬品工業株式会社 Heterocyclic compounds
EP3087060B1 (en) 2013-12-23 2020-05-13 Merck Sharp & Dohme Corp. Pyrimidone carboxamide compounds as pde2 inhibitors
US9849132B2 (en) 2014-01-08 2017-12-26 Intra-Cellular Therapies, Inc. Products and pharmaceutical compositions
MA50375A (en) 2014-04-23 2021-05-26 Dart Neuroscience Cayman Ltd COMPOSITIONS CONTAINING [1,2,4] TRIAZOLO [1,5-A] PYRIMIDINE-7-YL SUBSTITUTE COMPOUNDS USED AS PDE2 INHIBITORS
TWI568737B (en) 2014-11-05 2017-02-01 達特神經科學（開曼）有限責任公司 Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as pde2 inhibitors
US10105349B2 (en) 2014-12-06 2018-10-23 Intra-Cellular Therapies, Inc. Organic compounds
KR102557603B1 (en) 2014-12-06 2023-07-19 인트라-셀룰라 써래피스, 인코퍼레이티드. Organic compounds
WO2016145614A1 (en) 2015-03-17 2016-09-22 Merck Sharp & Dohme Corp. Triazolyl pyrimidinone compounds as pde2 inhibitors
EP3285581B1 (en) 2015-03-26 2021-08-11 Merck Sharp & Dohme Corp. Pyrazolyl pyrimidinone compounds as pde2 inhibitors
US10195201B2 (en) 2015-05-05 2019-02-05 Merck Sharp & Dohme Corp. Heteroaryl-pyrimidinone compounds as PDE2 inhibitors
WO2016183741A1 (en) 2015-05-15 2016-11-24 Merck Sharp & Dohme Corp. Pyrimidinone amide compounds as pde2 inhibitors
WO2016191935A1 (en) 2015-05-29 2016-12-08 Merck Sharp & Dohme Corp. 6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors
WO2016192083A1 (en) 2015-06-04 2016-12-08 Merck Sharp & Dohme Corp. Dihydropyrazolopyrimidinone compounds as pde2 inhibitors
EP3313852B1 (en) 2015-06-25 2021-01-20 Merck Sharp & Dohme Corp. Substituted pyrazolo/imidazolo bicyclic compounds as pde2 inhibitors
WO2017000276A1 (en) 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
WO2017000277A1 (en) 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Substituted triazolo bicycliccompounds as pde2 inhibitors
WO2019101970A1 (en) 2017-11-23 2019-05-31 Oslo University Hospital Hf Treatment of tachycardia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK109578A (en) 1977-03-25 1978-09-26 Allen & Hanburys Ltd PROCEDURE FOR MAKING HETEROCYCLIC COMPOUNDS
DE19541264A1 (en) 1995-11-06 1997-05-07 Bayer Ag Purin-6-one derivatives
DE19709877A1 (en) 1997-03-11 1998-09-17 Bayer Ag 1,5-dihydro-pyrazolo [3,4-d] pyrimidinone derivatives
HU230154B1 (en) * 1997-11-12 2015-09-28 Bayer Intellectual Property Gmbh Process for the preparation of 2-phenyl substituted imidazotriazinones
DE19827640A1 (en) 1998-06-20 1999-12-23 Bayer Ag New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction
DE19838705A1 (en) 1998-08-26 2000-03-02 Bayer Ag New dihydro- (1,2,3) -triazolo- [4,5-d] pyrimidin-7-ones

Also Published As

Publication number Publication date
CA2431965A1 (en) 2002-06-27
WO2002050078A1 (en) 2002-06-27
PE20020756A1 (en) 2002-10-02
EP1347978B1 (en) 2005-08-31
DOP2001000297A (en) 2003-08-15
JP2004525098A (en) 2004-08-19
AU2002216087A1 (en) 2002-07-01
UY27080A1 (en) 2002-07-31
EP1347978A1 (en) 2003-10-01
AR034423A1 (en) 2004-02-25
HN2001000281A (en) 2003-02-04
US6573263B2 (en) 2003-06-03
GT200100254A (en) 2002-08-19
DE10064105A1 (en) 2002-06-27
US20020198377A1 (en) 2002-12-26
ES2248228T3 (en) 2006-03-16
DE50107316D1 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
SV2002000776A (en) NEW SUBSTITUTED IMIDAZOTRIAZINONES REF.LEA 34 985-SV
SV2004001432A (en) 2-TIO-3,5-DICIANO-4-4FENIL-6-SUBSTITUTED AMINOPIRIDINS AND ITS USE REF. READ 35 640-SV
SV2003001172A (en) 2-TIO-3,5-DICIANO-4-FENIL-6-SUBSTITUTED AMINOPIRIDINS AND ITS USE REF. READ 35510-SV
SE9802729D0 (en) Novel Compounds
SE0301653D0 (en) Novel compounds
SV1997000003A (en) TIENIL- AND FURANIL-OXAZOLIDINONES PIRIDOCONDENSADAS REF. READ 31502-SV
HN2002000300A (en) NEW DERIVATIVES OF PIPERAZINA
ECSP045081A (en) DERIVATIVES OF 1,8-NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS
CY1111119T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING COGLIDES
UY28312A1 (en) REPLACED PIRAZOLOPIRIMIDINES WITH 6-CYCLIMETY AND 6-RENT
SV2001000004A (en) DIFENIL UREAS W-CARBOXYARIL SUBSTITUTED, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THEIR USE AS RAF QUINASA INHIBITORS
BR9713499A (en) Halogenopyrimidines
BR0114903A (en) 7-azaindoles, their application as phosphodiesterase 4 inhibitors and processes for their preparation
BR0114379A (en) Substituted c-cyclohexylmethylamine derivatives
HN2001000235A (en) DERIVATIVES BRIDGES OF PIPERAZINA
BR0114380A (en) 1-Aminobutan-3-ol-substituted derivatives
SV2002000355A (en) ARIL- AND HETEROARILSULFONATOS REF. READ 34321-SV
PA8509601A1 (en) "PIRAZOLO [4,3, e] NOVEDOUS REPLACED DIAZEPINS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, ITS USE AS MEDICINAL PRODUCTS AND PROCESSES TO PREPARE THEM
SE0102910D0 (en) New use
BRPI0414732A (en) pyridylacetylenes for use as radiotracers and imaging agents
SV2002000639A (en) PHENOXYPHENYL ALCANOSULFONATES REF. READ 34813-SV
ES2157419T3 (en) ARILAZADIOXACICLOALQUENOS SUBSTITUIDOS, FUNGICIDAS.
BR0114459A (en) Substituted 5-amino-1-penten-3-ol substituted derivatives
NO20021429L (en) 1,4-dioxacycloalkan-2-one and 1,4-dioxacycloalken-2-one
SV2004001441A (en) ISOCROMANO COMPOUNDS REF. X-14205